Dezima Pharma dezimapharma.com


Dezima Pharma develops drugs to treat dyslipidemia, a major modifiable risk for cardiovascular disease. Dezima's objective is to develop compounds from pre-clinical development to meaningful proof of concept (PoC) in patients.

Dezima Pharma develops drugs to treat dyslipidemia, a major modifiable risk for cardiovascular disease. Dezima's objective is to develop compounds from pre-clinical development to meaningful proof of concept (PoC) in patients.

Company (Acquired)

Phone: +31 35 699 30 00

Fax:

Gooimeer 2 - 35

Naarden, 1411
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Dezima Pharma $18.5M Sep 16, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Dezima Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)